Article Text

Download PDFPDF
Short-term intraocular pressure trends following intravitreal injections of ranibizumab (Lucentis) for the treatment of wet age-related macular degeneration

Statistics from Altmetric.com

Footnotes

  • Funding: Research supported by an unrestricted grant from the Research to Prevent Blindness Organization, New York, NY.

  • Competing interests: None.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.